We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+9.48%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$34.5B
AUM Growth
+$1.76B
(+5.4%)
Cap. Flow
-$769M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
26.77%
Holding
1,963
New
176
Increased
1,051
Reduced
620
Closed
112
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Albemarle
ALB
|
+$68.7M |
| 2 |
GE HealthCare
GEHC
|
+$28.6M |
| 3 |
ON Semiconductor
ON
|
+$28.1M |
| 4 |
Caterpillar
CAT
|
+$22.6M |
| 5 |
IBM
IBM
|
+$20.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$94.9M |
| 2 |
Apple
AAPL
|
+$91M |
| 3 |
West Pharmaceutical
WST
|
+$69M |
| 4 |
FISV
Fiserv Inc
FISV
|
+$61.8M |
| 5 |
Amazon
AMZN
|
+$55.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Industrials | 12.05% |
| 3 | Consumer Staples | 10.74% |
| 4 | Consumer Discretionary | 10.51% |
| 5 | Healthcare | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Globus Medical
GMED
$10.4B
| $287K | ﹤0.01% |
4,827
-103
| -2% | -$5.87K |
|
|
VGR
1302
DELISTED
Vector Group Ltd.
VGR
| $287K | ﹤0.01% |
22,380
+1,868
| +9% | +$23K |
|
|
HIMX
1303
Himax Technologies
HIMX
$2.2B
| $287K | ﹤0.01% |
42,460
+9,791
| +30% | +$68.7K |
|
1304
ACV Auctions
ACVA
$1.35B
| $286K | ﹤0.01% |
16,536
+2,665
| +19% | +$40.7K |
|
1305
Opendoor
OPEN
$3.7B
| $285K | ﹤0.01% |
+73,384
| New | +$159K |
|
1306
LiveRamp
RAMP
$2.29B
| $285K | ﹤0.01% |
9,991
+731
| +8% | +$18.1K |
|
1307
NovoCure
NVCR
$2.04B
| $285K | ﹤0.01% |
6,872
-439
| -6% | -$27.3K |
|
1308
National Health Investors
NHI
$3.9B
| $285K | ﹤0.01% |
5,433
+515
| +10% | +$26.5K |
|
1309
Corcept Therapeutics
CORT
$10.2B
| $285K | ﹤0.01% |
12,798
+15
| +0.1% | +$345 |
|
1310
Flowserve
FLS
$9.25B
| $285K | ﹤0.01% |
7,661
-113
| -1% | -$3.92K |
|
1311
H&R Block
HRB
$5.18B
| $284K | ﹤0.01% |
8,896
-164
| -2% | -$5.3K |
|
1312
IonQ
IONQ
$12.3B
| $283K | ﹤0.01% |
20,918
+6,771
| +48% | +$56.3K |
|
|
RC
1313
Ready Capital
RC
$265M
| $283K | ﹤0.01% |
25,062
+13,955
| +126% | +$147K |
|
1314
Cinemark Holdings
CNK
$3.82B
| $283K | ﹤0.01% |
17,130
+1,378
| +9% | +$22.9K |
|
1315
CEVA Inc
CEVA
$1.01B
| $283K | ﹤0.01% |
11,062
+1,316
| +14% | +$33.1K |
|
1316
Helios Technologies
HLIO
$2.64B
| $282K | ﹤0.01% |
4,265
+435
| +11% | +$25.8K |
|
|
DADA
1317
DELISTED
Dada Nexus
DADA
| $281K | ﹤0.01% |
52,841
+27,792
| +111% | +$168K |
|
1318
Vericel Corp
VCEL
$2.3B
| $279K | ﹤0.01% |
7,436
+593
| +9% | +$19.5K |
|
1319
Harmonic Inc
HLIT
$1.21B
| $279K | ﹤0.01% |
17,238
+3,407
| +25% | +$54.7K |
|
|
MAXN
1320
DELISTED
Maxeon Solar Technologies
MAXN
| $279K | ﹤0.01% |
99
-21
| -18% | -$60.1K |
|
1321
Urban Edge Properties
UE
$2.94B
| $278K | ﹤0.01% |
18,024
+1,351
| +8% | +$19.5K |
|
1322
Alpha Metallurgical Resources
AMR
$1.82B
| $277K | ﹤0.01% |
1,687
-106
| -6% | -$16.2K |
|
|
EQC
1323
DELISTED
Equity Commonwealth
EQC
| $277K | ﹤0.01% |
13,658
+1,323
| +11% | +$27.4K |
|
|
STR
1324
DELISTED
Sitio Royalties
STR
| $276K | ﹤0.01% |
+10,505
| New | +$269K |
|
1325
Plains GP Holdings
PAGP
$5.23B
| $275K | ﹤0.01% |
18,573
+467
| +3% | +$6.45K |
|
Similar funds
ProShare Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, ProShare Advisors held 1,963 positions worth $34.5B, up 5.4% from $32.7B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
ProShare Advisors's Q2 2023 filing shows 176 new, 1,051 increased, 620 reduced and 112 closed positions. Its largest new stake was Artesian Resources: 162,581 shares worth $7.68M. The largest sale was Microsoft, an estimated $94.9M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Consumer Staples.
- ProShare Advisors's largest Q2 2023 buy was Artesian Resources: 162,581 shares worth $7.68M.
- ProShare Advisors added most to Albemarle in Q2 2023, an estimated $68.7M increase.
- ProShare Advisors's biggest Q2 2023 reduction was Microsoft, cutting an estimated $94.9M.
- ProShare Advisors fully exited Rivian in Q2 2023, selling an estimated $11.9M.
- ProShare Advisors's ten largest holdings make up 27% of its $34.5B portfolio in Q2 2023.
- ProShare Advisors opened 176 new positions and closed 112 in Q2 2023.
- ProShare Advisors's portfolio value rose 5.4% quarter-over-quarter to $34.5B.
Based on ProShare Advisors's 13F filing for Q2 2023, filed 10 Aug 2023.